Cited by 180Coffee research and impactsNutritional Studies and DietMental Health Treatment and Access

Coffee and caffeine consumption and depression: a meta-analysis of observational studies

Wang, Longfei, Shen, Xiaoli, Wu, Yili, Zhang, Dongfeng·2016·Australian & New Zealand Journal of Psychiatry

Abstract

OBJECTIVE: The results from observation studies on the relationship between coffee intake and risk of depression and the relationship between caffeine consumption and depression remain controversial. We conducted a meta-analysis with a dose-response analysis to quantitatively summarize the evidence about the association between coffee and caffeine intakes and risk of depression. METHOD: Relevant articles were identified by researching PubMed, Web of Science, China National Knowledge Infrastructure and WANFANG DATA in English or Chinese from 1 January 1980 to 1 May 2015. Case-control, cohort or cross-sectional studies evaluating coffee or caffeine consumption and depression were included. A random-effects model was used to combine study-specific relative risk and 95% confidence interval. Dose-response relationship was assessed by restricted cubic spline functions. RESULTS: Data were obtained from 11 observation articles; 330,677 participants from seven studies in seven articles were included in the coffee-depression analysis, while 38,223 participants from eight studies in seven articles were involved in the caffeine-depression analysis. Compared with the lowest level consumption, the pooled relative risk (95% confidence interval) for coffee-depression and caffeine-depression was 0.757 [0.624, 0.917] and 0.721 [0.522, 0.997], respectively. For dose-response analysis, evidence of a linear association was found between coffee consumption and depression, and the risk of depression decreased by 8% (relative risk = 0.92, 95% confidence interval = [0.87, 0.97], p = 0.002) for each cup/day increment in coffee intake; a nonlinear association was found between caffeine consumption and depression, the risk of depression decreased faster and the association became significant when the caffeine consumption was above 68 mg/day and below 509 mg/day. CONCLUSIONS: Coffee and caffeine consumption were significantly associated with decreased risk of depression.

Integrity signals

Registry

Crossref · 10.1177/0004867415603131

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For some psychiatric illnesses such as Parkinson's disease, Alzheimer's disease, and depression, caffeine antagonism of adenosine receptors may improve symptoms and slow the progression of neurodegeneration, although these findings are equivocal with some studies reporting caffeine increases depressive symptoms.

    “For some psychiatric illness, such as Parkinson’s disease, Alzheimer’s disease, and depression, caffeine antagonism of adenosine receptors may improve symptoms (204, 205) and slow the progression of neurodegeneration (206, 207), although these findings are equivocal with some studies reporting caffeine increases depressive symptoms (208).”

    From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [205]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, L., Shen, X., Wu, Y., & Zhang, D.
Affiliations
Qingdao University (CN)
Corresponding author
Zhang, Dongfeng
Venue
Australian & New Zealand Journal of Psychiatry
Published
2015-09-02
Volume
50
Issue
3
Pages
228-242
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2158213691
Cited by
180
References
35
Citations by year
2026: 11 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 22 · 2021: 25 · 2020: 16 · 2019: 14 · 2018: 14 · 2017: 11 · 2016: 6
FWCI
1.30
Type
journal article
Language
en
Open access
closed
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Coffee research and impacts
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
coffee consumption, caffeine consumption, depression, dose-response relationship, nonlinear relationship, depression risk
MeSH terms
Caffeine, Coffee, Depression, Dose-Response Relationship, Drug, Humans, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review